The report provides comprehensive information on the
therapeutics under development for Age Related Macular Degeneration, complete
with analysis by stage of development, drug target, mechanism of action (MoA),
route of administration (RoA) and molecule type. The report also covers the
descriptive pharmacological action of the therapeutics, its complete research
and development history and latest news and press releases. Additionally, the
report provides an overview of key players involved in therapeutic development
for Age Related Macular Degeneration and features dormant and discontinued
projects.
Get Sample Report @ https://www.wiseguyreports.com/sample-request/535862-age-related-macular-degeneration-pipeline-review-h1-2016
Report features investigational drugs from across globe
covering over 20 therapy areas and nearly 3,000 indications. Drug profiles
featured in the report undergoes periodic review following a stringent set of
processes to ensure that all the profiles are updated with the latest set of
information. Additionally, various dynamic tracking processes ensure that the
most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging
players in the market and their portfolios, enhances decision making
capabilities and helps to create effective counter strategies to gain
competitive advantage.
Scope
- The report provides a snapshot of the global therapeutic
landscape of Age Related Macular Degeneration
- The report reviews pipeline therapeutics for Age Related
Macular Degeneration by companies and universities/research institutes based on
information derived from company and industry-specific sources
- The report covers pipeline products based on various
stages of development ranging from pre-registration till discovery and
undisclosed stages
- The report features descriptive drug profiles for the
pipeline products which includes, product description, descriptive MoA, R&D
brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Age Related
Macular Degeneration therapeutics and enlists all their major and minor
projects
- The report assesses Age Related Macular Degeneration
therapeutics based on drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued
pipeline projects
- The report reviews latest news related to pipeline
therapeutics for Age Related Macular Degeneration
Reasons to buy
- Gain strategically significant competitor information,
analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product
portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of
therapeutics under development for Age Related Macular Degeneration
- Identify potential new clients or partners in the target
demographic
- Develop strategic initiatives by understanding the focus
areas of leading companies
- Plan mergers and acquisitions effectively by identifying
key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by
understanding Age Related Macular Degeneration pipeline depth and focus of
Indication therapeutics
- Develop and design in-licensing and out-licensing
strategies by identifying prospective partners with the most attractive
projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying
discontinued projects and understanding the factors that drove them from
pipeline
Table of
Contents
Table of Contents 2
Introduction 8
Age Related Macular Degeneration Overview 9
Therapeutics Development 10
Age Related Macular Degeneration - Therapeutics under
Development by Companies 12
Age Related Macular Degeneration - Therapeutics under
Investigation by Universities/Institutes 23
Age Related Macular Degeneration - Pipeline Products Glance
24
Age Related Macular Degeneration - Products under Development
by Companies 28
Age Related Macular Degeneration - Products under
Investigation by Universities/Institutes 40
Age Related Macular Degeneration - Companies Involved in
Therapeutics Development 41
Age Related Macular Degeneration - Therapeutics Assessment
157
Drug Profiles 172
Age Related Macular Degeneration - Recent Pipeline Updates
436
Age Related Macular Degeneration - Dormant Projects 535
Age Related Macular Degeneration - Discontinued Products 549
Age Related Macular Degeneration - Product Development
Milestones 550
Appendix 557
Access Report @ https://www.wiseguyreports.com/reports/535862-age-related-macular-degeneration-pipeline-review-h1-2016
Contact Info:
NORAH TRENT
Partner Relations
& Marketing Manager
Ph:
+1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Get
in touch:
LinkedIn:
www.linkedin.com/company/4828928
Twitter:
https://twitter.com/WiseGuyReports
No comments:
Post a Comment